Inventor · disambiguated record
Jia Li
Also filed as: LI JIA · LI JIA-DA
7 granted patents·4 pending applications·5 citations·filing 2008–2022
74Inventor score
Files withLIAO XIBIN3ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO LTD3BIOPOLAR HONGYE GUANGDONG PHARMACEUTICAL CO LTD2ZHOU QUN-YONG2HANGZHOU HEALZEN THERAPEUTICS CO LTD1
Top patents by PatentIndex Score
11 records- 0185US11554118B2Bruton's tyrosine kinase inhibitorsLIAO XIBIN·Filed 2018·Granted Jan 17, 2023·2 cites·6 claims
- 0280US10933063B2Bruton's tyrosine kinase inhibitorsLIAO XIBIN·Filed 2019·Granted Mar 2, 2021·1 cites·3 claims
- 0371US8722896B2Prokineticin receptor antagonists and uses thereofZHOU QUN-YONG·Filed 2009·Granted May 13, 2014·2 cites·12 claims
- 0466US11974999B2Bruton's tyrosine kinase inhibitorsLIAO XIBIN·Filed 2021·Granted May 7, 2024·0 cites·4 claims
- 0550US2024360146A1Bruton's tyrosine kinase and mutant degrader, composition and application thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0646US2023167114A1Macrocyclic jak inhibitor and use thereofBIOPOLAR HONGYE GUANGDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0746US2023203059A1Macrocyclic jak inhibitor and uses thereofBIOPOLAR HONGYE GUANGDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0845US2010286021A1Methods of Modulating Prokineticin 2 for Treatment of Stress Response and Anxiety-Related DisordersZHOU QUN-YONG·Filed 2008·Application pending·0 cites
- 0943US10793566B2Bruton's tyrosine kinase inhibitorsZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 6, 2020·0 cites·8 claims
- 1038US10358446B2Bruton's tyrosine kinase inhibitorsZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 23, 2019·0 cites·6 claims
- 1136US10662187B2Bruton's tyrosine kinase inhibitorsZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO LTD·Filed 2017·Granted May 26, 2020·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Jia Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →